SCHEMBL6763025

SCHEMBL6763025

NS(=O)(=O)Cc1cc(Br)ccc1OCC(=O)N1[C@@H]2CC[C@H]1CC(Oc1ccc(F)cc1)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.39
HSD17B10 Q99714 1/20 0.39
NAAA Q02083 1/20 0.38
CCR1 P32246 1/20 0.36
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
EPHX2 P34913 1/20 0.34
GRIN1 Q05586 2/20 0.34
GRIN2B Q13224 2/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
RAB9A P51151 1/20 0.34
OPRK1 P41145 2/20 0.33
KCNH2 Q12809 2/20 0.33
OPRM1 P35372 1/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33
PKM P14618 1/20 0.33
RECQL P46063 1/20 0.33
TP53 P04637 1/20 0.33
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6763027 1.00 MAPK1 (0.39) MAPK1HSD17B10NAAACCR1MEN1
SCHEMBL6761239 0.90 CCR1 (0.46) NAAACCR1EPHX2PTGDR2OPRK1
SCHEMBL6761243 0.90 CCR1 (0.46) NAAACCR1EPHX2PTGDR2OPRK1
SCHEMBL6762776 0.88 MAPK1 (0.40) MAPK1HSD17B10NAAACCR1MEN1
SCHEMBL6762783 0.88 MAPK1 (0.40) MAPK1HSD17B10NAAACCR1MEN1
SCHEMBL6760359 0.88 MAPK1 (0.51) MAPK1HSD17B10NAAACCR1MEN1
SCHEMBL6760357 0.88 MAPK1 (0.51) MAPK1HSD17B10NAAACCR1MEN1
SCHEMBL6761869 0.88 MAPK1 (0.38) MAPK1HSD17B10NAAACCR1MEN1
SCHEMBL6761307 0.86 CCR1 (0.42) MAPK1HSD17B10NAAACCR1MEN1
SCHEMBL6761310 0.86 CCR1 (0.42) MAPK1HSD17B10NAAACCR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063688-A1 Novel piperidine derivatives PFIZER INC. 2004-04-01 US claimed
US-20040063688-A1 Novel piperidine derivatives PFIZER INC. 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063688-A1 Novel piperidine derivatives CCR1, CCR3, CCR2 MAPK1 438/4885HSD17B10 4377/4885NAAA 4622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.